Update on Invasive Fungal Infections, ESCMID Postgraduate Education Course
8 - 9 November 2007, Innsbruck, Austria
Organizer
ESCMID, EFISG (ESCMID Fungal Infection Study Group), AFST-EUCAST (Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing), and the Department of Medical Hygiene and Social Medicine of Innsbruck.
Course Objectives
Yeasts and moulds have emerged during the past two decades as important causes of morbidity and mortality in some group of patients. At present Candida and Aspergillus spp. are the most common causes of invasive fungal infections (IFI) but Mucorales and other rare and emerging species are increasingly reported.
The specific objectives of the workshop are:
- Review the present epidemiological situation of IFI
- Evaluate conventional methods and new techniques for diagnosis of IFI
- Learn appropriate methods for susceptibility testing including commercial techniques
- Teach criteria for prophylaxis and treatment of IFI
- Inform about rare and emerging fungal species
- Define priorities and exchange experiences on how to coordinate microbiological data and clinical practice
Presentations
All presentations are available for ESCMID Members. Please log in or register.
- Present epidemiological situation of Medical Mycology
J Peter Donnelly, Nijmegen, The Netherlands
Presentation not available - Rare and emerging fungal pathogens
Manuel Cuenca-Estrella, Majadahonda, Spain - Antifungal Susceptibility Testing (AFST)
Juan Luis Rodriguez-Tudela, Majadahonda, Spain - Case Study 1. How to coordinate microbiological data and clinical practice?
J Peter Donnelly, Nijmegen, The Netherlands
Presentation not available - Case Study 2. How can we determine the susceptibility profile of isolates from patients with invasive fungal infections (IFI)?
Manuel Cuenca-Estrella, Majadahonda, Spain - Case Study 3. Usefulness of AFST results. Practical approach
Juan Luis Rodriguez-Tudela, Majadahonda, Spain - Prophylaxis and pre-emptive treatment. Criteria and therapeutic options
Guenter Weiss, Innsbruck, Austria - Treatment of IFI. Antifungal armamentarium
Olivier Lortholary, Paris, France - Diagnostic methods of IFI
Cornelia Lass-Floerl, Innsbruck, Austria - Case Study 4. How to reduce the prevalence of IFI?
Guenter Weiss, Innsbruck, Austria - Case Study 5. How to improve the survival time of patients suffering from IFI?
Olivier Lortholary, Paris, France - Case Study 6. Patient suffering from IFI. Diagnostic options
Cornelia Lass-Floerl, Innsbruck, Austria
Presentation not available


